ID: h-bf8abdb5
Hypothesis
Combinatorial Epigenetic Therapy Targeting REST Convergence Hub
Combinatorial Epigenetic Therapy Targeting REST Convergence Hub.
🧬 REST pathway + combinatorial HDAC/DNMT inhibition🩺 neurodegeneration🎯 Composite 42%💱 $0.48▲15.1%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 4 support✗ 5 oppose
🧪 Overview
Combinatorial Epigenetic Therapy Targeting REST Convergence Hub
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["REST/NRSF Transcriptional Repressor<br/>Neuronal Gene Silencing Factor"]
B["GABAergic and Synaptic Gene Suppression<br/>Non-neuronal Cell Identity Maintenance"]
C["Tau and ATXN2 Modulation<br/>Neurodegeneration Linkage"]
D["REST Deficiency in Aging<br/>Neurotoxic Gene Derepression"]
E["Neuronal Identity Loss<br/>Synaptic Vulnerability"]
F["REST Activating Compounds<br/>Neuroprotective Target Validation"]
G["AD and FTD Mechanisms<br/>REST-Dependent Protection Failure"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
style A fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style F fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix4 supports5 contradicts
Supports
REST is downregulated in AD, PD, and ALS, correlating with increased neuronal vulnerability
Supports
Combined HDAC/DNMT inhibition shows synergistic transcriptional reactivation in cancer models
Supports
Valproate has been safely used in clinical trials for neurological conditions with acceptable CNS penetration
Contradicts
Combinatorial toxicity - combining HDAC + DNMT inhibitors increases adverse effect risk with narrow therapeutic indices
Contradicts
REST has context-dependent functions - protective in excitotoxicity but potentially detrimental in other contexts
Contradicts
REST downregulation may be a protective response allowing neuronal stress adaptation
Contradicts
Cancer synergy data may not apply to post-mitotic neurons where cell cycle re-entry is harmful
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — REST
No curated PDB or AlphaFold mapping for REST yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for REST pathway + combinatorial HDAC.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.7%
Volatility
Low
0.0062
Events (7d)
2
Price History
▲15.1%💾 Resource Usage
LLM Tokens
34,738
$0.1042
Total Cost
$0.1042
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF 3-month-old 5xFAD mice receive 8-week intraperitoneal treatment with SAHA (10 mg/kg) + 5-aza-dC (0.5 mg/kg) thrice weekly, THEN spatial memory retention will improve by ≥25% in Morris water maze (l | ≥25% reduction in platform search latency during probe trial and ≥20% reduction in cortical Aβ42 ELISA levels versus vehicle. | — no observation — | pending | 0.55 |
| IF primary cortical neurons from a 5xFAD mouse model are treated for 7 days with combinatorial SAHA (1 µM) + 5-aza-2'-deoxycytidine (1 µM), THEN REST target gene expression (Bdnf exon IV, Ngn1, Syn1) | ≥30% upregulation of REST target genes by qRT-PCR with p<0.05, alongside maintained cell viability (>90% by Calcein-AM). | — no observation — | pending | 0.65 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF primary cortical neurons from a 5xFAD mouse model are treated for 7 days with combinatorial SAHA (1 µM) + 5-aza-2'-deoxycytidine (1 µM), THEN REST target gene expression (Bdnf exon IV, Ngn1, Syn1) will increase ≥30% compared to vehicle or single-agent controls.
Predicted outcome: ≥30% upregulation of REST target genes by qRT-PCR with p<0.05, alongside maintained cell viability (>90% by Calcein-AM).
Falsification: No significant change in REST target gene expression (<15% change, p>0.05) or cytotoxicity (>20% decrease in viability) compared to vehicle controls.
pendingconf 55%
IF 3-month-old 5xFAD mice receive 8-week intraperitoneal treatment with SAHA (10 mg/kg) + 5-aza-dC (0.5 mg/kg) thrice weekly, THEN spatial memory retention will improve by ≥25% in Morris water maze (latency reduction) and cortical amyloid-β burden will decrease ≥20% versus vehicle controls.
Predicted outcome: ≥25% reduction in platform search latency during probe trial and ≥20% reduction in cortical Aβ42 ELISA levels versus vehicle.
Falsification: No significant improvement in spatial memory performance (p>0.05 between groups) or no reduction in cortical Aβ42 (<15% change) after 8-week treatment.
▸Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
| source | v1_phase_c_backfill |
| origin_type | gap_debate |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.